SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is currently trending following a significant $816 million contract award to build 18 missile-defense satellites for the U.S. Space Force, marking its largest deal to date. This substantial win has fueled intense community discussion about its growing role in the space and defense sector, with many anticipating further upside from upcoming catalysts like the Neutron rocket and the broader momentum in space stocks. Sentiment suggests strong conviction that this contract validates Rocket Lab's position alongside larger prime contractors and could trigger short-covering activity.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending due to a positive analyst rating from KeyBanc and mounting anticipation for a key NASA Lunar Terrain Vehicle (LTV) contract award. The community is actively discussing the potential for a short squeeze, viewing LUNR as a front-runner in the heating up space exploration sector. This sentiment, bolstered by broader governmental focus on American space superiority, is driving significant trading volume.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending as political discourse intensifies around healthcare costs, with public statements calling for insurance companies to reduce prices. The community is actively debating the potential for a market impact, with some anticipating declines for the sector while others view the rhetoric as political maneuvering that could still lead to long-term benefits for diversified players like UNH. Additional discussions include the potential implications of ongoing talks about ACA subsidies and the company's recently adopted operational improvements following independent audits.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following its proposed merger with a nuclear fusion company, dramatically shifting its business focus into the speculative energy sector. This pivot is driving intense debate among investors, with supporters touting it as a visionary move for energy independence and significant future growth, while skeptics warn of substantial dilution and question the viability of merging a social media platform with a pre-revenue technology venture. The discussion is further amplified by broader political discourse, contributing to high volatility and strong polarization in community sentiment surrounding the stock.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network ($ZBCN) is trending as the community eagerly anticipates confirmed ISO 20022 compliance and the launch of its Super App, alongside recent strategic partnerships with entities like NatPay, Fasset, and Dash. Discussions highlight Zebec's foundational work in real-time compliant payments, leading many to accumulate and stake tokens. This robust development in payment infrastructure and global utility is driving comparison to established compliant digital assets, with community members expressing strong conviction for significant long-term growth despite observed market fluctuations.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is experiencing a strong rally, largely attributed to its selection for a U.S. Department of Energy initiative and a renewed 'Buy' rating from analysts. The community is actively discussing a massive short squeeze, with many expressing strong bullish conviction about its strategic importance in the rapidly expanding AI infrastructure sector.

NovaBay Pharmaceuticals, Inc. engages in the development and sales of scientifically-created and clinically-proven eyecare and skincare. Its products include Avenova, NeutroPhase and DERMAdoctor. The company was founded on January 19, 2000 and is headquartered in Emeryville, CA.

Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals is trending with intense trading activity, driven by a recent analyst "buy" rating and an upcoming special cash dividend. Community discussion is focused on the company's hinted pivot towards blockchain-based assets and its historically high short interest, contributing to significant volatility and mixed sentiment.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending on strong bullish sentiment driven by the imminent BlueBird 6 satellite launch and anticipation of an expedited launch schedule, with multiple subsequent launches planned. The community is also highly focused on the recent signing of the Golden Dome defense bill, which is expected to unlock significant government contracts for commercial space solutions and is seen as a major catalyst for the company and the broader space sector.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is trending following the FDA approval of MYQORZO (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy, a groundbreaking treatment that has ignited significant community discussion. Investors are highlighting its favorable REMS program and differentiated profile compared to existing therapies, positioning it as a potential new standard of care in the sector. This pivotal regulatory milestone continues to fuel ongoing speculation regarding potential future acquisition interest in the company.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg Commerce is trending as investors are intensely focused on continuous share accumulation by insider Vlad Galkins, who is nearing 20% ownership, which dramatically tightens the tradable float. This insider confidence and recent strategic partnerships are fueling widespread community discussion about a potential short squeeze, despite ongoing concerns over market manipulation and artificial price suppression.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Recommendation of "Moderate Buy" by Analysts

Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the six analysts that are covering the company, Marketbeat reports. One investment...

Vivo Capital LLC Decreases Stake in Delcath Systems, Inc. $DCTH

Vivo Capital LLC cut its stake in shares of Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 24.1% during the second quarter, according to the company in its most recent filing with the...

Delcath Systems, Inc. $DCTH Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC boosted its holdings in Delcath Systems, Inc. (NASDAQ:DCTH - Free Report) by 128.1% during the second quarter, according to its most recent Form 13F filing with the SEC...

Do Options Traders Know Something About Delcath Systems Stock We Don't?

Investors need to pay close attention to Delcath Systems stock based on the movements in the options market lately.

Delcath Systems, Inc. (NASDAQ:DCTH) Given Consensus Rating of "Moderate Buy" by Brokerages

Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six ratings firms that are presently covering the firm, Marketbeat.com...

Delcath Systems (NASDAQ:DCTH) Board Authorizes Stock Repurchase Plan

Delcath Systems (NASDAQ:DCTH - Get Free Report) announced that its Board of Directors has approved a share repurchase program on Thursday, November 20th, RTT News reports. The company plans to...

Delcath Systems Board of Directors Authorizes $25 Million Share Repurchase Program

Delcath Systems, Inc. (Nasdaq: DCTH), (Delcath) an interventional oncology company focused on the treatment of primary and metastatic cancers to the liver, today announced that its Board of Directors...

Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma

Delcath Systems, Inc. (Nasdaq: DCTH), (Delcath or the Company) an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of...

Delcath Systems (NASDAQ:DCTH) CEO Gerard Michel Acquires 11,500 Shares of Stock

Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) CEO Gerard Michel bought 11,500 shares of the firm's stock in a transaction dated Tuesday, November 11th. The shares were purchased at an average...

Delcath Systems (NASDAQ:DCTH) CEO Gerard Michel Acquires 11,500 Shares

Delcath Systems, Inc. (NASDAQ:DCTH - Get Free Report) CEO Gerard Michel purchased 11,500 shares of Delcath Systems stock in a transaction that occurred on Tuesday, November 11th. The shares were...

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

DCTH
Delcath Systems Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DCTH News

DCTHDelcath Systems Inc